Login

WANdisco's partnership with IBM uniquely enables the active replication of data across hybrid, cloud, and on-premises environments.|David Richards, CEO of WANdisco PLC 00:10:00

Share On Facebook Share On Twitter

David Richards, CEO of WANdisco PLC

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Simona Grossi, CEO of Greenthesis Spa, leads an industrially evolving group committed to sustainability and innovation.
00:10:00
Venture is Eating the Investment World|Ali Hamed,General Partner,Crossbeam Venture Partners
00:10:00
Insights on Financial Inclusion: Bridging Gaps and Transforming Lives
00:10:00
Why Florida Announces Election Results Quickly|Lawer Ben
00:10:00
Blackrock Graphite: From Scoping Study to Bankable Feasibility in Tanzania
00:10:00
Triumph and Tragedy: Unveiling the Vietnam War's Lessons and Legacy|Mark Moyar,Professor,Hillsdale College
00:10:00
Silverstorm Mining: High-Grade Drilling Results and Strategic Focus on Production
00:10:00
Insights from São Paulo's Water Crisis and Environmental Initiatives | Benedito Braga, CEO, Companhia de Saneamento Basico do Estado de Sao Paulo SABESP.
00:10:00
Critical Elements Lithium's Roadmap: Advancing Rose Project Amid Permitting Milestones and Strategic Investments
00:10:00
About Us: Embracing the FFP Way | John Graziano - President, Wealth Management Partner of FFP Wealth Management
00:10:00
Jon Gilligan of Liberty Gold Corp. and Joe Mazumdar of Exploration Insights discuss open-pit oxide gold deposits in the prolific Great Basin region, focusing on flagship projects Black Pine and Goldstrike at Metals Investor Forum.|Jon Gilligan, President
00:10:00
SkinBioTherapeutics is targeting five specific skin healthcare sectors|Stuart Ashman,Chief Executive,Skinbiotherapeutics

© 2026 Nehu